Skip to content

Clinical trials

Phase 1/2 Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 1/2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20131
20141
20172
20192
20201
20211
20223
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status5
Recruiting3
Active, not recruiting2
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LYSOGENE2
Amylyx Pharmaceuticals Inc.1
AskBio France, SAS, a subsidiary of AskBio Inc.1
Calico Life Sciences LLC1
Chinese University of Hong Kong1
ClusterXStem-Costa Rica1
Helixmith Co., Ltd.1
Herantis Pharma Plc.1
Hong Kong University of Science and Technology1
Maimónides Biomedical Research Institute of Córdoba1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases19
Nervous System Diseases8
Parkinson Disease6
Brain Diseases5
Central Nervous System Diseases5
Movement Disorders5
Dementia4
Genetic Diseases, Inborn4
Alzheimer Disease3
Amyotrophic Lateral Sclerosis3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.